Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha
- PMID: 9537326
- DOI: 10.1038/32925
Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha
Abstract
Although hypoxia (lack of oxygen in body tissues) is perhaps the most physiological inducer of the wild-type p53 gene, the mechanism of this induction is unknown. Cells may detect low oxygen levels through a haem-containing sensor protein. The hypoxic state can be mimicked by using cobalt chloride and the iron chelator desferrioxamine: like hypoxia, cobalt chloride and desferrioxamine activate hypoxia-inducible factor 1alpha (HIF-1alpha), which stimulates the transcription of several genes that are associated with hypoxia. Here we show that these treatments induce accumulation of wild-type p53 through HIF-1alpha-dependent stabilization of p53 protein. Induction of p53 does not occur in either a mutant hepatoma cell line that is unable to induce HIF-1alpha or embryonic stem cells derived from mice lacking HIF-1beta. HIF-1alpha is found in p53 immunoprecipitates from MCF7 cells that express wild-type p53 and are either hypoxic or have been exposed to desferrioxamine. Similarly, anti-haemagglutinin immunoprecipitates from lysates of normoxic PC3M cells that had been co-transfected with haemagglutinin-tagged HIF-1alpha and wild-type p53 also contain p53. Transfection of normoxic MCF7 cells with HIF-1alpha stimulates a co-transfected p53-dependent reporter plasmid and increases the amount of endogenous p53. Our results suggest that hypoxic induction of transcriptionally active wild-type p53 is achieved as a result of the stabilization of p53 by its association with HIF-1alpha.
Similar articles
-
Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction.Cancer Res. 1998 Dec 15;58(24):5678-80. Cancer Res. 1998. PMID: 9865721
-
Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.Biochem Biophys Res Commun. 1999 Jul 5;260(2):557-61. doi: 10.1006/bbrc.1999.0878. Biochem Biophys Res Commun. 1999. PMID: 10403805
-
Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.Cancer Res. 2000 Oct 15;60(20):5630-4. Cancer Res. 2000. PMID: 11059752
-
Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.Oncogene. 2001 Jan 18;20(3):395-8. doi: 10.1038/sj.onc.1204055. Oncogene. 2001. PMID: 11313969 Review.
-
HIF-1 and p53: communication of transcription factors under hypoxia.J Cell Mol Med. 2004 Oct-Dec;8(4):423-31. doi: 10.1111/j.1582-4934.2004.tb00467.x. J Cell Mol Med. 2004. PMID: 15601571 Free PMC article. Review.
Cited by
-
Low molecular weight fucoidan against renal ischemia-reperfusion injury via inhibition of the MAPK signaling pathway.PLoS One. 2013;8(2):e56224. doi: 10.1371/journal.pone.0056224. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418539 Free PMC article.
-
Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors.Oncogene. 2020 Jul;39(29):5228-5239. doi: 10.1038/s41388-020-1359-4. Epub 2020 Jun 17. Oncogene. 2020. PMID: 32555333 Free PMC article.
-
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy.Hypoxia (Auckl). 2015 Dec 11;3:83-92. doi: 10.2147/HP.S93413. eCollection 2015. Hypoxia (Auckl). 2015. PMID: 27774485 Free PMC article. Review.
-
Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.Mol Neurobiol. 2006 Aug;34(1):27-50. doi: 10.1385/mn:34:1:27. Mol Neurobiol. 2006. PMID: 17003520 Review.
-
HIF-1alpha: a valid therapeutic _target for tumor therapy.Cancer Res Treat. 2004 Dec;36(6):343-53. doi: 10.4143/crt.2004.36.6.343. Epub 2004 Dec 31. Cancer Res Treat. 2004. PMID: 20368827 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous